An interventional study of Dexmedetomidine and Dexamethasone in Postoperative Pain, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-07-30.
Sponsored by Assiut University · Not applicable, Interventional, and Prevention
Single-injection peripheral nerve block (PNB) is commonly used for perioperative analgesia and anesthesia. Three approaches for extending the duration of PNB include continuous PNB with catheter-based techniques, novel local anesthetics delivery systems and addition of novel adjuvants to local anesthetics.
5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.
This study's enrollment of 90 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Dexmedetomidine
Drug: Dexamethasone
dexmedetomedine added to bupivacaine for adductor canal block
dexamethasone added to bupivacaine for adductor canal block
visual analogue scale score
scale of 11 points. zero=no pain, 10 = worest pain ever
Time frame: 24 hours postoperative
analgesia duration
pain free duration after block
Time frame: 24 hours postoperative
opioid consumption
amount of opioid consumed postoperative
Time frame: 24 hours postoperative
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University